Increased in R&D activities & governmental funding, rise in adoption of a multiplex assay to reduce operation cost, and surge in adoption of personalized medicines are expected to propel the growth of the global multiplex assay market. The market across Asia-Pacific is projected to portray the fastest CAGR of 10.2% during the forecast period. On the other hand, the protein-based multiplex assays segment held the largest share in 2018, contributing more than three-fourths of the market.

Portland, OR, Aug. 08, 2019 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global multiplex assay market was pegged at $73.2 million in 2018 and is projected to reach $123.1 million by 2026, registering the fastest CAGR 6.6% from 2019 to 2026.

Rise in R&D activities & governmental funding, increase in adoption of multiplex assay to reduce operation costs, and surge in adoption of personalized medicines have boosted the growth of the global multiplex assay market. However, lack of skilled labor and healthcare professionals hampers the market growth. On the contrary, untapped potential in the emerging economies is expected to create lucrative opportunities in the near future.

Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/1921

The global multiplex assay market is divided into type, product, technology, application, end user, and geography. Based on type, the market is segmented into nucleic acid-based multiplex assays, protein-based multiplex assays, and others. The protein-based multiplex assays segment held the largest share in 2018, contributing more than three-fourths of the market. However, the nucleic acid-based multiplex assays segment is projected to manifest the fastest CAGR of 9.1% during the forecast period.

On the basis of product, the market is bifurcated into multiplex assay reagents & consumables, multiplex assay accessories & instruments, and multiplex assay software & services. The reagents and consumables segment dominated the market, accounting for nearly three-fourths of the market. However, the instruments & accessories segment is estimated to register the fastest CAGR of 8.7% during the forecast period.

Based on end user, the market is divided into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. The pharmaceutical and biotechnology companies held the lion’s share in 2018, contributing more than half of the market share in 2018 and is projected to register the fastest CAGR of 8.1% by 2026.

The global multiplex assay market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Asia-Pacific is projected to portray the fastest CAGR of 10.2% during the forecast period. However, the market across North America held the largest share in 2018, contributing more than two-fifths of the market.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1921

The market report provides an in-depth analysis of the major market players such as Thermo Fisher Scientific Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Illumina Inc., Becton, QIAGEN N.V., Abcam PLC, Dickinson and Company, Meso Scale Diagnostics LLC, Seegene Inc., and Randox Laboratories Ltd.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada): 
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com